Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2512]

Selective expression of the follicle-stimulating hormone receptor on the surface of tumour blood vessels

Selective expression of the follicle-stimulating hormone receptor on the surface of tumour blood vessels

Prostate cancer clinical stage does not predict recurrence

Prostate cancer clinical stage does not predict recurrence

Prostate cancer clinical stage does not predict recurrence

Prostate cancer clinical stage does not predict recurrence

PARP inhibitor, MK-4827, shows anti-tumour activity in first trial in humans

PARP inhibitor, MK-4827, shows anti-tumour activity in first trial in humans

Prostate cancer drug targeting Vitamin D receptors shows promise

Prostate cancer drug targeting Vitamin D receptors shows promise

What we are reading this week at the European Institute of Oncology

What we are reading this week at the European Institute of Oncology

COSA 2010: Up to 97% of men impotent after some prostate cancer treatments

COSA 2010: Up to 97% of men impotent after some prostate cancer treatments

Risk of colorectal cancer increases in prostate cancer patients on androgen deprivation therapy

Risk of colorectal cancer increases in prostate cancer patients on androgen deprivation therapy

$AACR Frontiers in Cancer Prevention Research: Use of androgen deprivation therapy increases fracture risk among prostate cancer patients$

AACR Frontiers in Cancer Prevention Research: Use of androgen deprivation therapy increases fracture risk among...

AACR Frontiers in Cancer Prevention Research: Long-term statin use is unlikely to increase cancer risk

AACR Frontiers in Cancer Prevention Research: Long-term statin use is unlikely to increase cancer risk

More from ecancer